JP2023509463A5 - - Google Patents
Info
- Publication number
- JP2023509463A5 JP2023509463A5 JP2022541285A JP2022541285A JP2023509463A5 JP 2023509463 A5 JP2023509463 A5 JP 2023509463A5 JP 2022541285 A JP2022541285 A JP 2022541285A JP 2022541285 A JP2022541285 A JP 2022541285A JP 2023509463 A5 JP2023509463 A5 JP 2023509463A5
- Authority
- JP
- Japan
- Prior art keywords
- particles
- therapeutic
- therapeutic agent
- group
- combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025153243A JP2025178320A (ja) | 2020-01-03 | 2025-09-16 | 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062956795P | 2020-01-03 | 2020-01-03 | |
| US62/956,795 | 2020-01-03 | ||
| PCT/US2021/012015 WO2021138646A1 (en) | 2020-01-03 | 2021-01-03 | Systems and pharmaceutical compositions for treatment by direct injection of a targeted population of cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025153243A Division JP2025178320A (ja) | 2020-01-03 | 2025-09-16 | 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509463A JP2023509463A (ja) | 2023-03-08 |
| JP2023509463A5 true JP2023509463A5 (https=) | 2024-01-11 |
Family
ID=76687575
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541285A Pending JP2023509463A (ja) | 2020-01-03 | 2021-01-03 | 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物 |
| JP2025153243A Pending JP2025178320A (ja) | 2020-01-03 | 2025-09-16 | 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025153243A Pending JP2025178320A (ja) | 2020-01-03 | 2025-09-16 | 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230103552A1 (https=) |
| EP (1) | EP4084828A4 (https=) |
| JP (2) | JP2023509463A (https=) |
| KR (1) | KR20220125798A (https=) |
| CN (2) | CN121421961A (https=) |
| AU (1) | AU2021204918A1 (https=) |
| BR (1) | BR112022013270A2 (https=) |
| CA (1) | CA3166633A1 (https=) |
| WO (1) | WO2021138646A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3015172A1 (en) | 2016-02-18 | 2017-08-24 | Privo Technologies, Inc. | Two-stage microparticle-based therapeutic delivery system and method |
| WO2018151849A1 (en) | 2017-02-17 | 2018-08-23 | Privo Technologies, Inc. | Particle-based multi-layer therapeutic delivery device and method |
| US10478403B1 (en) | 2017-05-03 | 2019-11-19 | Privo Technologies, Inc. | Intraoperative topically-applied non-implantable rapid release patch |
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| KR20240041285A (ko) | 2021-06-01 | 2024-03-29 | 프리보 테크놀로지스, 인코포레이티드 | 향상된 2단계 미세입자 기반 국소 치료제 전달 시스템 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| KR20250123284A (ko) | 2024-02-07 | 2025-08-18 | 순천향대학교 산학협력단 | 클릭화학을 이용한 약물 봉입 엑소좀 유사체의 제조 방법 및 약물 봉입 엑소좀 유사체 |
| CN121221639A (zh) * | 2025-10-11 | 2025-12-30 | 中山大学附属第五医院 | 一种负载难溶性中药小分子阿可拉定hp@ict水凝胶、及其制备方法与应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR960016882A (ko) * | 1994-11-01 | 1996-06-17 | 강재헌 | 치주염치료를 위한 서방출형 생분해성 제제 |
| AU2001253334A1 (en) | 2000-04-10 | 2001-10-23 | Teva Pharmaceutical Industries Ltd. | Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
| US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
| MX2007003789A (es) * | 2004-10-04 | 2007-07-20 | Qlt Usa Inc | Suministro ocular de formulaciones polimericas para suministro. |
| US7867984B1 (en) * | 2005-01-04 | 2011-01-11 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
| US8242165B2 (en) * | 2006-10-26 | 2012-08-14 | Creighton University | Mucoadhesive nanoparticles for cancer treatment |
| ES2562878T3 (es) * | 2007-05-25 | 2016-03-08 | Indivior Uk Limited | Formulaciones de liberación sostenida de compuestos de risperidona |
| WO2009158145A2 (en) * | 2008-05-30 | 2009-12-30 | Allergan, Inc. | Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form |
| EP2306991B1 (en) * | 2008-06-27 | 2019-12-25 | Tepha, Inc. | Injectable delivery of microparticles and compositions therefore |
| US20170136127A1 (en) * | 2014-07-01 | 2017-05-18 | Vicus Therapeutics, Llc | Hydrogels for treating and ameliorating cancers and potentiating the immune system and methods of making and using them |
| CA3015172A1 (en) * | 2016-02-18 | 2017-08-24 | Privo Technologies, Inc. | Two-stage microparticle-based therapeutic delivery system and method |
| WO2018151849A1 (en) * | 2017-02-17 | 2018-08-23 | Privo Technologies, Inc. | Particle-based multi-layer therapeutic delivery device and method |
| US10478403B1 (en) * | 2017-05-03 | 2019-11-19 | Privo Technologies, Inc. | Intraoperative topically-applied non-implantable rapid release patch |
-
2021
- 2021-01-03 CA CA3166633A patent/CA3166633A1/en active Pending
- 2021-01-03 US US17/758,205 patent/US20230103552A1/en active Pending
- 2021-01-03 BR BR112022013270A patent/BR112022013270A2/pt unknown
- 2021-01-03 WO PCT/US2021/012015 patent/WO2021138646A1/en not_active Ceased
- 2021-01-03 CN CN202511559365.2A patent/CN121421961A/zh active Pending
- 2021-01-03 EP EP21736181.5A patent/EP4084828A4/en active Pending
- 2021-01-03 CN CN202180018850.2A patent/CN115243722A/zh active Pending
- 2021-01-03 KR KR1020227026296A patent/KR20220125798A/ko active Pending
- 2021-01-03 JP JP2022541285A patent/JP2023509463A/ja active Pending
- 2021-01-03 AU AU2021204918A patent/AU2021204918A1/en active Pending
-
2025
- 2025-09-16 JP JP2025153243A patent/JP2025178320A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023509463A5 (https=) | ||
| EP2817011B1 (en) | Treatment of cancer | |
| TWI732773B (zh) | 用於奈米顆粒冷凍乾燥形式的組成物及方法 | |
| JP2022531939A5 (https=) | ||
| RU2019138742A (ru) | Средства для химиоэмболизации | |
| TW201711697A (zh) | 抗－ｃｇｒｐ抗體調配物 | |
| TWI813571B (zh) | 防沉澱的小分子藥調配物 | |
| JP2025020319A (ja) | テルリプレシン組成物およびその使用方法 | |
| CN115243722A (zh) | 通过直接注射靶细胞群进行治疗的系统和药物组合物 | |
| CN102309458A (zh) | 海藻酸钠交联莫西沙星缓释微球、其制备方法和用途以及含有所述微球的血管靶向栓塞剂 | |
| JP2016155826A (ja) | 経口薬物療法のための方法および組成物 | |
| CN112004528B (zh) | 载药微珠组合物、栓塞组合物和相关方法 | |
| CN104306325B (zh) | 一种抗肿瘤水凝胶的制备方法 | |
| US10085973B2 (en) | Pharmaceutical composition containing a compound having a thrombopoietin receptor agonistic activity | |
| JP5698296B2 (ja) | 静脈内投与による有効成分制御放出のための生体適合性を有するアルギン酸微粒子組成物 | |
| KR20170109221A (ko) | 저분자 메틸셀룰로오스 기반의 비경구 약물 전달 시스템 | |
| WO2019170912A1 (en) | Bioresorbable controlled-release compositions with sting modulating molecules | |
| WO2026060885A1 (zh) | 一种生物相容性良好的控释释药微针及其制备方法 | |
| CN105999273A (zh) | 一种用于关节炎治疗的复方制剂 | |
| CN104546722A (zh) | 米铂脂质体和制法 | |
| CN101185629A (zh) | 一种治疗实体肿瘤的地西他滨缓释剂 | |
| Vikas et al. | Alginate-based hydrogels as drug carriers | |
| Zhang et al. | Advancements in neovascular ophthalmopathy: therapeutic strategies and future prospects | |
| CN102670611A (zh) | 抗结核药物三联复方微球血管靶向栓塞缓释剂及其制备方法和用途 | |
| CN110227158A (zh) | 一种用于靶向治疗的载体化疗药物 |